Anthelmintics for people with neurocysticercosis-Reference-Cited by-同舟云学术

Anthelmintics for people with neurocysticercosis

Published:2010-03-17 Issue: Volume: Page:
ISSN:
Container-title:Cochrane Database of Systematic Reviews
language:
Short-container-title:

Author:

Abba Katharine,Ramaratnam Sridharan,Ranganathan Lakshmi Narasimhan

Publisher

John Wiley & Sons, Ltd

Reference53 articles.

1. Neurocysticercosis: short course of treatment with albendazole;Alarcon;Archives of Neurology,1989

2. Short course of albendazole therapy for neurocysticercosis: a prospective randomized trial comparing three days, eight days and the control group without albendazole;Alarcon;Revista Ecuatoriana De Neurologia,2001

3. Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo controlled, double-blind trial;Baranwal;Pediatric Infectious Disease Journal,1998

4. Morphometry of single small enhancing computed tomographic lesions: outcome and effect of albendazole therapy;Baranwal;Journal of Tropical Pediatrics,2002

5. Seizure recurrence and single small enhancing computed tomographic lesions: prognostic factors on long-term follow-up;Baranwal;Journal of Child Neurology,2001

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural basis for the recognition of anthelmintic activity of bioactive metabolite in watery rose apple leaf through in silico investigation;Journal of Biomolecular Structure and Dynamics;2023-12-12

2. Fourteen Days vs 28 Days of Albendazole Therapy for Neurocysticercosis in Children: An Open Label Randomized Controlled Trial;Indian Pediatrics;2022-10-29

3. In vitro metabolic stress induced by nitazoxanide and flubendazole combination in Taenia crassiceps cysticerci;Experimental Parasitology;2022-07

4. Neurocysticercosis: an update on diagnosis, treatment, and prevention;Current Opinion in Infectious Diseases;2022-06

5. An update on Neurocysticercosis-related epilepsy;Clinical Neurology and Neurosurgery;2022-02